Pulmonary vascular dysfunction in metabolic syndrome
- PMID: 30125956
- PMCID: PMC6375868
- DOI: 10.1113/JP275856
Pulmonary vascular dysfunction in metabolic syndrome
Abstract
Metabolic syndrome is a critically important precursor to the onset of many diseases, such as cardiovascular disease, and cardiovascular disease is the leading cause of death worldwide. The primary risk factors of metabolic syndrome include hyperglycaemia, abdominal obesity, dyslipidaemia, and high blood pressure. It has been well documented that metabolic syndrome alters vascular endothelial and smooth muscle cell functions in the heart, brain, kidney and peripheral vessels. However, there is less information available regarding how metabolic syndrome can affect pulmonary vascular function and ultimately increase an individual's risk of developing various pulmonary vascular diseases, such as pulmonary hypertension. Here, we review in detail how metabolic syndrome affects pulmonary vascular function.
Keywords: Diabetes; Insulin resistance; dyslipidemia; obesity; pulmonary artery; pulmonary hypertension.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.
References
-
- Agarwal M, Agrawal S, Garg L & Lavie CJ (2017). Relation between obesity and survival in patients hospitalized for pulmonary arterial hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011). Am J Cardiol 120, 489–493. - PubMed
-
- Ahren B, Mansson S, Gingerich RL & Havel PJ (1997). Regulation of plasma leptin in mice: influence of age, high‐fat diet, and fasting. Am J Physiol Regul Integr Comp Physiol 273, R113–R120. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical